An innovative perspective for heart attack patients

Cardiovascular disease is a serious problem. Worldwide, the number of heart attacks is increasing and 30% of those affected have to deal with severe consequences. A new CRP apheresis procedure is designed to help minimize the severity of tissue destruction and subsequent damage.

Have you ever heard of CRP apheresis? Do you know what effects CRP can have on heart attacks or harmful inflammation? We’ve done the research for you and additionally found out exciting companies that have established themselves in the field of myocardial research. Learn more in our new arcoro CONNECT.

Facts at a glance

Inflammatory events and infections cause the formation of the CRP protein, which can lead to an increase in primary damage in the case of internal organ damage. A new, innovative therapy should now help to reduce CRP and promises patients after heart attacks or other illnesses reduced damage and more performance.

Your contact person

Anne Plonz

Business Analyst

Email: plonz@arcoro.de

Download Connect (PDF)

Field of expertise

Your request to us

We connect people with opportunities and knowledge

We are here for you! Whether project inquiries, market information or the desire for an active cooperation. We have a sympathetic ear for your concerns and are sure we can help quickly.